Home › Interstitial Lung Diseases › Florida › Jacksonville
Interstitial Lung Diseases clinical trials in Jacksonville, FL
5 studies for Interstitial Lung Diseases are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- Mayo Clinic Florida, Jacksonville
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- Mayo Clinic of Florida, Jacksonville
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Jacksonville
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
- Mayo Clinic, Jacksonville
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
Recruiting
- Mayo Clinic in Florida, Jacksonville
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY17 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Houston, TX12 studies
- Chicago, IL12 studies
- Charleston, SC11 studies
- Ann Arbor, MI11 studies
- Aurora, CO10 studies
- Boston, MA9 studies
- Rochester, MN9 studies
Other studies in Jacksonville
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)29 studies
- Metastatic Cancer27 studies
- Colorectal Cancer25 studies
- Prostate Cancer25 studies
- Obesity25 studies
- Pancreatic Cancer21 studies
- Heart Failure20 studies
- Overweight19 studies
- Multiple Myeloma19 studies
- Lung Cancer18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.